FITC Anti-Human CD56 Antibody[MEM188]

The FITC Anti-Human CD56 Antibody [MEM188] is a highly specific and reliable tool designed for the detection and analysis of CD56 expression in human samples. This monoclonal antibody is conjugated with fluorescein isothiocyanate (FITC), a fluorochrome known for its exceptional brightness and stability, ensuring accurate and consistent results.

CD56, also known as neural cell adhesion molecule (NCAM), is a glycoprotein expressed on natural killer (NK) cells and a subset of T cells. It plays a crucial role in cell adhesion, migration, and signal transduction, making it an essential marker for the identification and characterization of these cell populations. The FITC Anti-Human CD56 Antibody [MEM188] specifically recognizes the extracellular domain of CD56, enabling precise detection and quantification of CD56-positive cells.

This antibody has been extensively validated for flow cytometry applications, providing researchers with a powerful tool for immunophenotyping studies. Its high specificity and low background staining ensure accurate identification and enumeration of CD56-positive cells in complex samples. The FITC conjugation allows for simultaneous detection of CD56 expression with other fluorochromes, facilitating multiparametric analysis and comprehensive characterization of cell populations.

The FITC Anti-Human CD56 Antibody [MEM188] is supplied as a ready-to-use reagent, eliminating the need for time-consuming and error-prone antibody conjugation procedures. It is provided in a convenient format, allowing for easy integration into existing laboratory protocols. The antibody is optimized for use with a variety of human sample types, including peripheral blood, bone marrow, and lymphoid tissues.

With its exceptional performance and reliability, the FITC Anti-Human CD56 Antibody [MEM188] is an indispensable tool for researchers studying NK cells and T cell subsets. Its high specificity, bright fluorescence, and ease of use make it an ideal choice for flow cytometry-based immunophenotyping experiments.